NovaResp Technologies Inc.
$176,772.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- September 1, 2022 – May 31, 2023
- Reference
- nrc-cnrc:172-2022-2023-Q3-995984
Published purpose
NovaResp Technologies Incorporated is a Canadian based corporation founded in 2016 with the goal of developing adaptive, self-learning airway management and providing truly proactive adaptation to patients’ respiratory needs. The company’s lead product – cMAP™- (Continuous monitoring of airway pressure) is a respiratory monitoring device and algorithm that can help positive airway pressure (PAP) machines respond proactively resulting in a safer, more comfortable solution for patients suffering from Sleep Apnea. The purpose of this project is to optimize cMAP™ to improve accuracy of the predictive, self-learning capabilities, while reducing computational cost.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.